Gilead Sciences
NASDAQ: GILD
$76.32
+$1.61 (+2.2%)
Closing price July 10, 2020
Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of remdesivir at...
13 days ago
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
17 days ago
The new attitude among investors about sustainability and societal impact probably will dominate discussion and investment choices in the years to come. Here are five of RBC's top picks in the arena...
24 days ago
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
Wednesday's top analyst upgrades and downgrades included Apache, Apple, CME, Devon Energy, Diamondback Energy, Gilead Sciences, Hexo, MarketAxess, Microchip Technology and Zoom Video Communications.
1 month ago
Last Updated: 1 month ago
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
1 month ago
In a world where investors are starving to find growth, many of the well established biotech leaders and many of the large pharmaceutical companies have been acquiring growth on top of their own...
1 month ago
Tuesday's top analyst upgrades and downgrades included Chembio Diagnostics, Cognex, Cree, Deere, Gilead Sciences, Halliburton, iRobot, Lam Research, Nvidia, Regeneron Pharmaceuticals, Sorrento...
1 month ago
Last Updated: 1 month ago
Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont and Royal Gold.
1 month ago
Last Updated: 1 month ago
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
2 months ago
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
2 months ago
Monday's top analyst upgrades and downgrades included Amazon.com, American Airlines, American Express, Beyond Meat, Caterpillar, Clorox, eBay, Gilead Sciences, Twitter, Verizon Communications and...
2 months ago
Last Updated: 2 months ago
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
2 months ago
Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago and Walt Disney.
2 months ago
Last Updated: 2 months ago
While the COVID-19 pandemic wrecked the stock market and the economy, the recent rally in the stock market has been at a time when the economic news is only getting worse and as coronavirus news...
2 months ago
Last Updated: 2 months ago